{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "decreases_activity",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "chebi:CHEBI:26523",
      "entity_text" : "ROS",
      "entity_type" : "simple_chemical"
    },
    "participant_a" : {
      "in_model" : true,
      "identifier" : "pubchem:11626560",
      "entity_text" : "crizotinib",
      "entity_type" : "simple_chemical"
    },
    "hypothesis_information" : false
  },
  "verbose_text" : "Thus, specific ROS inhibitors, such as crizotinib and foretinib, may provide approaches for the treatment of patients with liver cancer harboring ROS fusions.",
  "reading_complete" : "2020-08-02T15:23:04Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-02T15:22:15Z",
  "trigger" : "inhibitors",
  "evidence" : [ "ROS inhibitors, such as crizotinib" ],
  "pmc_id" : "4121345",
  "score" : 0
}